Report cover image

South Korea Ophthalmic Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

Published Aug 13, 2025
Length 75 Pages
SKU # MOI20473697

Description

South Korea Ophthalmic Devices Market Analysis

The South Korea ophthalmic devices market size is USD 1.25 billion in 2025 and will rise to USD 1.76 billion by 2030, translating into a 7.10% CAGR over the forecast period. Spiralling myopia rates, an older population that demands spectacle-free vision, and public reimbursements for early glaucoma detection underpin steady expansion. In 2024, vision-care products already accounted for 60.8% of the South Korea ophthalmic devices market as contact lenses, ortho-k lenses, and blue-light filters converged with fashion trends. Diagnostic hardware is catching up quickly; wide-field OCT angiography and AI-enabled fundus cameras are advancing at 9.23% CAGR on the back of new screening mandates. Hospitals command 43.6% of device placements, yet ambulatory surgery centres are carving share by offering day-case cataract and SMILE procedures. Multinational suppliers face long Ministry of Food and Drug Safety (MFDS) approval cycles, but they offset delays through joint ventures that localise service and training networks.

South Korea Ophthalmic Devices Market Trends and Insights

Rapid Adoption of Premium IOLs Among the Aging Population

Multifocal optics reshaped cataract workflows, climbing from 16% usage in 2018 to 29% in 2020 and seizing 53.56% of the domestic IOL segment in 2023. Femtosecond laser-assisted cataract surgery expanded from 5% to 29% of cases over the same period, aided by 96% penetration of optical biometry. RxSight’s Light Adjustable Lens delivered unaided 20/20 vision to 70% of recipients versus 40% with other premium alternatives, bolstering surgeon uptake.

Government Reimbursement Expansion for Nationwide Glaucoma Screening

New National Health Insurance rules cover wide-field OCT angiography, which shows 87.28% sensitivity and 86.94% specificity for glaucoma diagnosis compared with legacy OCT units. The initiative tackles disparities across 20 counties lacking any eye clinic, shrinking average travel time to specialised diagnostics.

Stringent MFDS Approval Timelines

AI-enabled scanners and new lens polymers fall into Class 3-4 risk categories. The Digital Medical Products Act of January 2024 demands extra cybersecurity validation, stretching launch cycles and raising documentation costs.

Other drivers and restraints analyzed in the detailed report include:

  1. High LASIK Penetration Driven by Cosmetic-Surgery Culture
  2. Surging Myopia Incidence in Adolescents
  3. Foreign-Exchange Cost Volatility

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Vision-care products controlled 60.81% of 2024 revenues as contact lenses served both corrective and cosmetic roles. The South Korea ophthalmic devices market continues to rely on repeat purchases of lens solutions, ortho-k modalities, and color tints. Diagnostic and monitoring systems post the quickest 9.23% CAGR. Their addressable value rises from USD 225 million in 2025 to an expected USD 345 million in 2030, anchoring future South Korea ophthalmic devices market size gains. Hospitals negotiate multi-year service contracts that bundle OCT hardware with AI subscription analytics, locking in predictable revenue for suppliers.

Surgical devices remain smaller but strategic. Femtosecond cataract platforms lifted operating efficiency and opened new premium IOL niches. Vendors now pitch disposable phaco tips and mobile surgical microscopes to ambulatory centres, a model suited to the South Korea ophthalmic devices market where outpatient cataract volumes are rising. Cross-licensing with Korean sensor makers shields multinationals from currency risk and qualifies them for preference points in public tenders.

The South Korea Ophthalmic Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, and Vision Care Devices), Disease Indication (Cataract, Glaucoma, Diabetic Retinopathy, and Other Disease Indication), End User (Hospitals, and More), Geography (North America, Europe, Asia-Pacific, The Middle East and Africa, and South America). The Market Forecasts are Provided in Terms of Value (USD).

List of Companies Covered in this Report:

  1. Alcon
  2. Carl Zeiss
  3. Johnson & Johnson Vision Care
  4. HOYA
  5. Topcon
  6. Nidek
  7. Bausch Health
  8. Glaukos
  9. STAAR Surgical
  10. HAAG-Streit
  11. Canon
  12. EssilorLuxottica
  13. CooperVision Inc.
  14. Menicon Co. Ltd.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

75 Pages
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rapid Adoption of Premium IOLs Among South Korea's Aging Population
4.2.2 Government Reimbursement Expansion for Nationwide Glaucoma Screening
4.2.3 High Penetration of LASIK Driven by Cosmetic-Surgery Culture
4.2.4 Growth of Private-Hospital Health Check-up Packages Featuring OCT
4.2.5 Surging Myopia Incidence in Adolescents Boosting Diagnostic Device Demand
4.2.6 Domestic AI-based Ophthalmic Diagnostic Start-ups Achieving MFDS Approvals
4.3 Market Restraints
4.3.1 Stringent MFDS Approval Timelines vs Global Peers
4.3.2 Foreign-Exchange Cost Volatility from Heavy Import Dependence
4.3.3 Shortage of Trained Ophthalmic Surgeons Outside Seoul Capital Area
4.3.4 Price Caps on Cataract Surgery Reimbursement Limiting Premium Devices
4.4 Regulatory Outlook
4.5 Porter's Five Forces Analysis
4.5.1 Threat of New Entrants
4.5.2 Bargaining Power of Buyers
4.5.3 Bargaining Power of Suppliers
4.5.4 Threat of Substitutes
4.5.5 Competitive Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Device Type
5.1.1 Diagnostic & Monitoring Devices
5.1.1.1 OCT Scanners
5.1.1.2 Fundus & Retinal Cameras
5.1.1.3 Autorefractors & Keratometers
5.1.1.4 Corneal Topography Systems
5.1.1.5 Ultrasound Imaging Systems
5.1.1.6 Perimeters & Tonometers
5.1.1.7 Other Diagnostic & Monitoring Devices
5.1.2 Surgical Devices
5.1.2.1 Cataract Surgical Devices
5.1.2.2 Vitreoretinal Surgical Devices
5.1.2.3 Refreactive Surgical Devices
5.1.2.4 Glaucoma Surgical Devices
5.1.2.5 Other Surgical Devices
5.1.3 Vision Care Devices
5.1.3.1 Spectacles Frames & Lenses
5.1.3.2 Contact Lenses
5.2 By Disease Indication
5.2.1 Cataract
5.2.2 Glaucoma
5.2.3 Diabetic Retinopathy
5.2.4 Other Disease Indications
5.3 By End-user
5.3.1 Hospitals
5.3.2 Specialty Ophthalmic Clinics
5.3.3 Ambulatory Surgery Centers (ASCs)
5.3.4 Other End-users
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and analysis of Recent Developments)
6.3.1 Alcon Inc.
6.3.2 Carl Zeiss Meditec AG
6.3.3 Johnson & Johnson Vision Care
6.3.4 Hoya Corporation
6.3.5 Topcon Corporation
6.3.6 Nidek Co. Ltd
6.3.7 Bausch & Lomb Inc.
6.3.8 Glaukos Corporation
6.3.9 STAAR Surgical Company
6.3.10 Haag-Streit Group
6.3.11 Canon Medical Systems Corp.
6.3.12 EssilorLuxottica SA
6.3.13 CooperVision Inc.
6.3.14 Menicon Co. Ltd.
7 Market Opportunities & Future Outlook
7.1 White-Space & Unmet-Need Assessment
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.